PROTAGONIST THERAPEUTICS INC (PTGX)

US74366E1029 - Common Stock

30.74  -1.2 (-3.76%)

After market: 30.74 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
60.00M26.58M27.36M28.63M230.00K
Operating Expenses
153.65M157.95M153.20M93.14M80.75M
Research and Development
120.16M126.22M126.01M74.51M65.00M
Selling, General, and Administrative Expenses
33.49M31.74M27.20M18.64M15.75M
Operating Income
-93.65M-131.37M-125.85M-64.51M-80.52M
Interest Income/Expense
14.90M4.06M440.00K300.00K2.64M
Other Income/Expense
-201.00K-80.00K-150.00K-50.00K0.00
Non Recurring Items
N/A0.000.00-590.00KN/A
Income Before Taxes
-78.95M-127.39M-125.55M-64.85M-77.88M
Income Tax
N/A0.000.001.31M-690.00K
Net Income
-78.95M-127.39M-125.55M-66.15M-77.19M
EBITDA
-92.67M-130.34M-125.04M-63.72M-79.82M
 
Per Share Data
EPS Diluted Total Ops
-1.39-2.60-2.71-1.92-2.98
Non GAAP EPS
-1.49-2.60-2.70-2.02-3.00
 
Statistics
Profit Margin
-131.59%-479.27%-458.88%-231.05%-33560.87%
Operating Profit Margin
-156.09%-494.24%-459.98%-225.32%-35008.70%

All data in USD

Charts